Managing the Side Effects of Psychotropic Medications, Second Edition
Joseph F. Goldberg, M.D., M.S., and Carrie L. Ernst, M.D.
Foreword by Stephen M. Stahl, M.D., Ph.D.
- 616 Pages
- Editorial Reviews
- ISBN 978-1-58562-488-1
- Item #62488
Information about new psychotropic drugs, a summary of advances in knowledge about identifiable risk factors for adverse effects, and updated recommendations on viable “antidote” management strategies—including novel pharmacotherapies for tardive dyskinesia and newer agents for weight loss—are among the features of this new, second edition of Managing the Side Effects of Psychotropic Medications.
Where other psychopharmacology textbooks—and, indeed, most internships and residencies in psychiatry—lack a solid basis in primary care medicine, this guide bridges that educational gap, offering a thorough examination of all the effects of taking a psychotropic drug as well practical clinical advice on how to manage complications that arise.
The book is divided into three parts: The first deals with global issues that affect the assessment and formulation of possible adverse effects, as well as with pertinent concepts related to basic pharmacology, physiology, and medical monitoring. The second part presents information organized by individual organ systems or specific medical circumstances. The final part focuses on summary recommendations covering all the material presented in the book and is followed by helpful appendixes and self-assessment questions and resources for practitioners.
This new edition includes:
- Updated summaries about what psychiatrists should know regarding drug-drug interactions, iatrogenic cardiac arrhythmias, drug pressor effects and orthostatic hypotension, and drug rashes; as well as updated discussions on avoiding lithium nephrotoxicity, handling adverse effect emergencies, and understanding new FDA classifications about drug safety during pregnancy
- An expanded discussion on the strengths and limitations of pharmacogenetic testing to predict adverse drug effects, as well as information about new treatments for sexual dysfunction, sleep disturbances, cognitive complaints, and other maladies
- Revised summary tables to aid rapid assessment and management
- An expanded section on supplemental resources
- An updated and expanded self-assessment section with more key questions
Busy clinicians will find in Managing the Side Effects of Psychotropic Medications an accessible reference that provides both scientific and scholarly discussion of the consequences of drug therapies they may prescribe (or avoid), the range of available strategies to effectively manage adverse effects, and the scientific and practical implications of their treatment decisions.
Foreword to the Second Edition
List of Abbreviations
List of Drugs
PART I: General Considerations
Chapter 1. The Psychiatrist as Physician
Chapter 2. Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics
Chapter 3. Vulnerable Populations
Chapter 4. Adverse Psychiatric Effects of Nonpsychotropic Medications
Chapter 5. Adverse Psychiatric Effects of Psychiatric Medications
Chapter 6. What Nonmedical Therapists Should Know About Adverse Drug Effects
PART II: Organ Systems
Chapter 7. Cardiovascular System
Chapter 8. Dermatological System
Chapter 9. Ear, Nose, and Throat
Chapter 10. Electrolyte Abnormalities
Chapter 11. Endocrinopathies
Chapter 12. Gastrointestinal System
Chapter 14. Hematological System
Chapter 15. Metabolic Dysregulation and Weight Gain
Chapter 16. Musculoskeletal System
Chapter 17. Neurological System
Chapter 18. Ophthalmological System
Chapter 19. Sleep Disturbances
Chapter 20. Systemic Reactions
Chapter 21. Pregnancy and the Puerperium
Chapter 22. Emergency Situations
PART III: Summary Recommendations
Chapter 23. Summary Recommendations
Appendix 1: Summary of Major Adverse Effects and Monitoring/Management Considerations
Appendix 2: Self-Assessment Questions and Answers
Appendix 3: Resources for Practitioners
Stephen M. Stahl, M.D., Ph.D.
Ross J. Baldessarini, M.D.
About the Authors
Joseph F. Goldberg, M.D., M.S., is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai in New York, New York.
Carrie L. Ernst, M.D., is Associate Professor of Psychiatry and Medical Education at the Icahn School of Medicine at Mount Sinai in New York, New York.
Goldberg and Ernst have updated their very valuable text Managing Side Effects of Psychotropic Medications in this second edition and it is a very welcome addition to the busy practitioner’s armamentarium. It provides in a single source important and often hard to find guidance on managing side effects of commonly (and uncommonly) prescribed psychiatric medications. It will be a very, very useful resource for psychiatrists, non-medically trained mental health professionals, nurses and students in a variety of fields. Their vast clinical experience is evident throughout the text .—Charles B. Nemeroff, M.D., Ph.D., Leonard M. Miller Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Clinical Director, Center on Aging, Chief of Psychiatry, Jackson Memorial Hospital, Chief of Psychiatry, University of Miami Hospital, Professor of Biochemistry and Molecular Biology, Leonard M. Miller School of Medicine, University of Miami
This is an impressive work. It is a comprehensive, thorough, scholarly, detailed, and practical book for clinicians, a thoughtful balance of art and science. The result is a tour de force that belongs on the bookshelves of psychiatrists and many others. —Alan J. Gelenberg, M.D.
Managing the Side Effects of Psychotropic Medications, 2nd Edition, has uniquely combined the art and science, the pragmatic and theoretical, yet throughout remains organically accessible and acutely relevant to decisions and choices in the clinical ecosystem. This erudite book will be of tremendous interest, and a must have, for all healthcare providers of persons receiving psychotropic agents, students of all levels, as well as individuals who are academically interested/involved. —Roger S. McIntyre, M.D., FRCPC, Professor of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada, Chairman and Executive Director, Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada, Director, Depression and Bipolar Support Alliance (DBSA), Chicago, USA, Head, Mood Disorders Psychopharmacology Unit